🧬 Companion Diagnostics (CDx) have become essential tools to realize the promise of precision oncology. But are current approaches to CDx keeping pace with the speed, efficiency, and scalability that pharma companies need? 🚀 At SOPHiA GENETICS’, we are rethinking the future of CDx. Our hybrid testing, powered by strategic partnerships, accelerates innovation, drives meaningful clinical and commercial impact, and strengthens health equity. 👉🏼 Read our article: https://loom.ly/Kedt2Yo #DataDrivenMedicine #PrecisionMedicine #Genomics #HealthEquity #CDx
